1.Zhu G, Gong W, Li J, et al. LncRNA MALAT1 promotes the apoptosis and oxidative stress of human lens epithelial cells via p38MAPK pathway in diabetic cataract. Diabetes Res Clin Pract. 2018, 144: 314-321.
2.Qi M, Elion E A. MAP kinase pathways[J]. Journal of Cell Science, 2005, 118(16): 3569-3572.
3.Collins JG, Corder CN. Aldose reductase and sorbitol dehydrogenase distribution in substructures of normal and diabetic rat lens. Invest Ophthalmol Vis Sci. 1977 Mar;16(3):242-3.
4.Hailiang W, De-Kuang H, Xudong S, et al. Association between Aqueous Cytokines and Diabetic Retinopathy Stage. Journal of Ophthalmology. Volume 2017.
5.Takeuchi M, Sato T, Sakurai Y, Taguchi M, Harimoto K, Karasawa Y, et al. (2017) Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy. PLoS ONE. 12(5): e0178230.
6.Kuzmin A, Lipatov D, Chistyakov T, et al. Vascular Endothelial Growth Factor in Anterior Chamber Liquid Patients with Diabetic Retinopathy, Cataract and Neovascular Glaucoma. Ophthalmol Ther (2013) 2:41–51.
7.Hamld S, Gul A, Hamld Q. Relationship of cytokines and AGE products in diabetic and non-diabetic patients with cataract. International Journal of Health Sciences, Qassim University, Vol. 10, No. 4.
8.Stephan Neumann, Jens Linek, Gerhard Loesenbeck, et al. TGF-β1 serum concentrations and receptor expressions in the lens capsular of dogs with diabetes mellitus. Open Veterinary Journal, (2017), Vol. 7(1): 12-15.
9.DeIongh R, Gordon-Thomson C, Chamberlain CG, et al. TGFbeta receptor expression in lens: Implication for differentiation and cataractogenesis. Exp Eye Res.(2001)72,649-659.
10.Lovicu FJ, Schulz MW, Hales AM, et al. TGFbeta induces morphological and molecular changes similar to human anterior subcapsular cataract. Br J Ophthalmol. 2002;86(2):220–226.
11.Ana Paula Arruda and Gökhan S. Hotamisligil. Calcium homeostasis and organelle function in the pathogenesis of obesity and diabetes. Cell Metab. 2015 September 1; 22(3): 381–397. doi:10.1016/j.cmet.2015.06.010.
12.Maddala R, Nagendran T, de Ridder GG, Schey KL, Rao PV (2013) L-Type Calcium Channels Play a Critical Role in Maintaining Lens Transparency by Regulating Phosphorylation of Aquaporin-0 and Myosin Light Chain and Expression of Connexins. PLoS ONE 8(5): e64676. doi:10.1371/journal.pone.0064676.
13.Chang C, Zhang K, Veluchamy A, et al. A genome-wide association study provides new evidence that CACNA1C gene is associated with diabetic cataract. Invest Ophthalmol Vis Sci. 2016;57:2246–2250.
14.He C, Zheng S, Luo Y, et al. Exosome Theranostics: Biology and Translational Medicine[J]. Theranostics, 2018, 8(1):237.
15.Samuelson I, Vidal-Puig AJ. Fed-EXosome: extracellular vesicles and cell-cell communication in metabolic regulation. Essays Biochem. 2018 May 15;62(2):165-175. doi: 10.1042/EBC20170087.
16.Liberman M, Marti LC. Vascular Calcification Regulation by Exosomes in the Vascular Wall. Adv Exp Med Biol. 2017;998:151-160. doi: 10.1007/978-981-10-4397-0_10.
17.Saeedi Borujeni MJ, Esfandiary E, Taheripak G, et al. Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome. J Cell Biochem. 2018 Feb;119(2):1257-1272. doi: 10.1002/jcb.26271.
18.Guay C, Regazzi R. Exosomes as new players in metabolic organ cross-talk. Diabetes Obes Metab. 2017 Sep;19 Suppl 1:137-146. doi: 10.1111/dom.13027.
19.Li J, Fu LZ, Liu L, et al. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Liraglutide Alters Bone Marrow Exosome-Mediated miRNA Signal Pathways in Ovariectomized Rats with Type 2 Diabetes. Med Sci Monit, 2017; 23: 5410-5419. doi: 10.12659/MSM.906603.
20.Poornima Venkat, Michael Chopp, Jieli Chen. Cell-Based and Exosome Therapy in Diabetic Stroke. STEM CELLS TRANSLATIONAL MEDICINE 2018;7:451-455.
21.Wang QH, Ding XQ, Zhen F, et al. Remedial applications of exosomes in cancer, infections and diabetes. Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 74 No. 2 pp. 313ñ320, 2017.
22.Zhang C, Zhang K, Huang FF, et al. Exosomes, the message transporters in vascular calcification. J Cell Mol Med. 2018;1–10. doi: 10.1111/jcmm.13692.
23.K. Agarwal, M. Saji, S. M. Lazaroff, et al. Analysis of Exosome Release as a Cellular Response to MAPK Pathway Inhibition. Langmuir. 2015 May 19; 31(19): 5440–5448. doi:10.1021/acs. langmuir.5b00095.
24.Sean M. Davidson , Jaime A. Riquelme, Kaloyan Takov, et al. Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro. J. Cell. Mol. Med. Vol 22, No 1, 2018 pp. 141-151. doi: 10.1111/jcmm.13302.
25.Lee MJ, et al. Exosomal biomarker development in metabolic diseases. Ann Pediatr Endocrinol Metab 2016;21:119-125.
26.W. Michael Dismuke, Pratap Challa, Iris Navarro, et al. Human Aqueous Humor Exosomes. Exp Eye Res. 2015 March ; 132: 73–77. doi:10.1016/j.exer.2015.01.019.
27.Marta Garcia-Contreras, Sanket H. Shah, Alejandro Tamayo, et al. Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes. Scientific Reports 7: 5998. doi:10.1038/s41598-017-05787-y.
28.Wang X, Huang W, Liu G, et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J Mol Cell Cardiol. 2014 September ; 74: 139–150. doi:10.1016/j.yjmcc.2014.05.001.
29.Wang X, Gu H, Huang W, et al. Hsp20-Mediated Activation of Exosome Biogenesis in Cardiomyocytes Improves Cardiac Function and Angiogenesis in Diabetic Mice. Diabetes 2016;65:3111–3128. DOI: 10.2337/db15-1563.
30.Kamalden TA, Macgregor-Das AM, Kannan SM, Dunkerly-Eyring B, Khaliddin N, Xu Z, Fusco AP, Yazib SA, Chow RC, Duh EJ et al: Exosomal MicroRNA-15a Transfer from the Pancreas Augments Diabetic Complications by Inducing Oxidative Stress. Antioxid Redox Signal 2017, 27(13):913-930.
31.Klingeborn M, Dismuke WM, Bowes RC, Stamer WD: Roles of exosomes in the normal and diseased eye. PROG RETIN EYE RES 2017, 59:158-177.
32.Huang C, Fisher KP, Hammer SS. Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway. Diabetes. 2018 Aug;67(8):1639-1649. doi: 10.2337/db17-1587.
33.B. Yan, J.T. Guo, C.D. Zhu, L.H. Zhao, J.L. Zhao, miR-203b: a novel regulator of MyoD expression in tilapia skeletal muscle, The Journal of experimental biology, 216 (2013) 447-451.
34.Gao C, Fan F, Liu X, et al. (2020) Exosomal miRNA Analysis of Aqueous Humour of Diabetes and Cataract Patients, Current Eye Research, DOI: 10.1080/02713683.2020.1797107
35.Sadaf Saba, Maryam Ghahramani and Reza Yousefi, A Comparative Study of the Impact of Calcium Ion on Structure, Aggregation and Chaperone Function of Human A-crystallin and its Cataract- Causing R12C Mutant, Protein & Peptide Letters (2017) 24: 1048.
36.Serra AM, Waddell J, Manivannan A, Xu H, Cotter M, Forrester JV: CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation. AM J PATHOL 2012, 181(2):719-727.
37.Knickelbein JE, Liu B, Arakelyan A, Zicari S, Hannes S, Chen P, Li Z, Grivel JC, Chaigne-Delalande B, Sen HN et al: Modulation of Immune Responses by Extracellular Vesicles From Retinal Pigment Epithelium. Invest Ophthalmol Vis Sci 2016, 57(10):4101-4107.
38.Xue LP, Fu XL, Hu M, et al. Rg1 inhibits high glucose-induced mesenchymal activation and fibrosis via regulating miR-2113/RP11-982M15.8/Zeb1 pathway. Biochem Biophys Res Commun. 2018 Jul 2;501(4):827-832. doi: 10.1016/j.bbrc.2018.04.055.
39.Shan K, Liu C, Liu BH, et al. Circulation. Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus. 2017 Oct 24;136(17):1629-1642.
40.Liu X, Liu C, Liu B, et al. Circular RNA HIPK3 regulates human lens epithelial cells proliferation and apoptosis by targeting the miR-193a/CRYAA axis. Biochem Biophys Res Commun. 2018 Jun 27. pii: S0006-291X(18)31468-2. doi: 10.1016/j.bbrc.2018.06.149.
41.Yury O. Nunez Lopez, Gabriella Garufi and Attila A. Seyhan. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes. Mol. BioSyst., 2017,13, 106-121.